Developed by Shray Alag, The Harker School
Sections: Correlations,
Clinical Trials, and HPO
Navigate: Clinical Trials and HPO
| Name (Synonyms) | Correlation | |
|---|---|---|
| drug447 | BBV152A - Phase I Wiki | 1.00 |
| drug449 | BBV152B - Phase I Wiki | 1.00 |
| drug451 | BBV152C - Phase I Wiki | 1.00 |
| Name (Synonyms) | Correlation | |
|---|---|---|
| D000370 | Ageusia NIH | 0.71 |
| D000857 | Olfaction Disorders NIH | 0.22 |
| D014777 | Virus Diseases NIH | 0.11 |
| Name (Synonyms) | Correlation | |
|---|---|---|
| HP:0000224 | Hypogeusia HPO | 0.71 |
| HP:0000458 | Anosmia HPO | 0.22 |
Navigate: Correlations HPO
There is one clinical trial.
Double blind, Multi-Centre study to evaluate the safety, reactogenicity, tolerability, and immunogenicity of three investigational vaccine groups and one placebo group in healthy volunteers who receive two intramuscular doses of BBV152 vaccine formulations and placebo. A total sample size of 755 healthy volunteers, with 375 and 380 volunteers in phase 1 and 2 studies, respectively.
Description: Safety
Measure: Phase 1: Occurrence of adverse events and Serious Adverse events Time: Through study completion, an average of 6 monthsDescription: Pre- and Post-vaccination immune response
Measure: Phase 2: Evaluation of Neutralizing Antibody Titers Time: Through study completion, an average of 6 monthsDescription: Pre- and Post-vaccination immune response
Measure: Phase 1: Evaluation of Neutralizing Antibody Titers Time: Through study completion, an average of 6 monthsDescription: Safety
Measure: Phase 2: Occurrence of adverse events and Serious Adverse events Time: Through study completion, an average of 6 monthsAlphabetical listing of all HPO terms. Navigate: Correlations Clinical Trials
Data processed on September 26, 2020.
An HTML report was created for each of the unique drugs, MeSH, and HPO terms associated with COVID-19 clinical trials. Each report contains a list of either the drug, the MeSH terms, or the HPO terms. All of the terms in a category are displayed on the left-hand side of the report to enable easy navigation, and the reports contain a list of correlated drugs, MeSH, and HPO terms. Further, all reports contain the details of the clinical trials in which the term is referenced. Every clinical trial report shows the mapped HPO and MeSH terms, which are also hyperlinked. Related HPO terms, with their associated genes, protein mutations, and SNPs are also referenced in the report.
Drug Reports MeSH Reports HPO Reports